Anterix Officer Sells $7.5M in Stock After Option Exercise
ATEX has more than doubled off its 52-week low of $17.58.
Summary
Anterix's Chief Regulatory & Communications Officer, Christopher Guttman-McCabe, sold over $7.5 million worth of company stock on the open market after exercising options.
Key Events · Ownership and Investor Activity · ATEX
-
Officer Sells Significant Stake
Christopher Guttman-McCabe, Chief Regulatory & Communications Officer, sold 91,437 shares for $7,539,884 on the open market.
-
Option Exercise Preceded Sale
The sale followed the exercise of 122,852 stock options, valued at $4,604,055, on the same day.
-
Substantial Reduction in Holdings
Post-transaction, the officer's direct holdings decreased to 169,244 shares.
-
Follows Insider Distribution Trend
This sale contributes to a recent trend of insider distribution, with net insider sales exceeding $2.2 million in the last 90 days.
Analysis · ATEX · Technology
This significant open market sale by Christopher Guttman-McCabe, Anterix's Chief Regulatory & Communications Officer, totaling over $7.5 million, represents a notable reduction in personal stake. While the shares were acquired through option exercises, the decision to immediately sell such a large portion on the open market is a strong negative signal, especially given recent positive news like FCC approval for experimental licenses and a reported financial turnaround. This sale contributes to a recent pattern of insider distribution, with net insider sales exceeding $2.2 million in the last 90 days.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 282 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ATEX was trading at $80.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $17.58 to $88.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.